CompletedNCT04221230
NMRA-335140 for Major Depression: Early Study
About this title
Read the official source — NCT04221230Researchers compared NMRA-335140 and placebo to find out how the approaches affected depression symptoms in people with depression.
Medication studyAges 18–65United States
Understand this study
What did researchers investigate?
Researchers compared NMRA-335140 and placebo to find out how the approaches affected depression symptoms in people with depression.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- Phoenix and 37 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: January 3, 2020
- Recruitment status
- Completed
- Enrollment listed in the registry
- 204
- Sponsor
- Neumora Therapeutics, Inc.
- Sponsor type
- Biotech company
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT04221230
- Official title
Show the full official title
A Phase 2a, Randomized, Double-blind, Placebo-controlled Proof of Concept Study to Evaluate the Effects of Oral BTRX-335140 (NMRA-335140) Versus Placebo in Subjects With Major Depressive Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Phoenix · Bentonville · Little Rock
32 more locations
- Bellflower
- Culver City
- Garden Grove
- Glendale
- Long Beach
- Oakland
- Riverside
- San Jose
- Santa Ana
- Sherman Oaks
- Torrance
- Upland
- Fernandina Beach
- Jacksonville
- Lauderhill
- Miami Lakes
- Orlando
- Sarasota
- Atlanta
- Decatur
- Las Vegas
- Berlin
- Brooklyn
- Jamaica
- New York
- Rochester
- Staten Island
- Dayton
- Oklahoma City
- Memphis
- Wichita Falls
- Clinton
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers compared NMRA-335140 and placebo to find out how the approaches affected depression symptoms in people with depression.
Who is behind this study?
The study sponsor is Neumora Therapeutics, Inc.
Did this study involve medication?
Yes. The study involved medication, including NMRA-335140 and Placebo.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
